Noxxon AG Report issue

For profit Phase 1 Phase 2
Founded: Berlin Germany (1997)

Organization Overview

First Clinical Trial
2009
NCT00976729
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

NOXXON Pharma AG